Apex Biotechnology Corp (1733) — Financial Flexibility Index
Apex Biotechnology Corp (1733) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of NT$8.16 Million (operating CF NT$5.19 Million minus capex NT$2.97 Million) represents 0% of total liabilities (NT$494.69 Million). Also explore Apex Biotechnology Corp (1733) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Apex Biotechnology Corp Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for Apex Biotechnology Corp across 23 annual periods. Check Apex Biotechnology Corp (1733) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Apex Biotechnology Corp (2002–2024)
Year-by-year free cash flow to debt coverage for Apex Biotechnology Corp. For the full company profile including market capitalisation, see market cap of Apex Biotechnology Corp.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.60x | NT$358.30 Million | NT$328.67 Million | NT$595.70 Million | ▲ +17.8% |
| 2023 | 0.51x | NT$255.37 Million | NT$230.39 Million | NT$500.07 Million | ▲ +432.6% |
| 2022 | 0.10x | NT$66.82 Million | NT$26.62 Million | NT$696.81 Million | ▼ -57.3% |
| 2021 | 0.22x | NT$206.07 Million | NT$179.87 Million | NT$916.91 Million | ▼ -31.3% |
| 2020 | 0.33x | NT$328.93 Million | NT$280.60 Million | NT$1.01 Billion | ▼ -28.3% |
| 2019 | 0.46x | NT$519.11 Million | NT$462.52 Million | NT$1.14 Billion | ▲ +188.1% |
| 2018 | 0.16x | NT$142.85 Million | NT$67.57 Million | NT$901.70 Million | ▲ +68.0% |
| 2017 | 0.09x | NT$97.59 Million | NT$70.83 Million | NT$1.03 Billion | ▼ -78.5% |
| 2016 | 0.44x | NT$336.51 Million | NT$298.06 Million | NT$768.49 Million | ▼ -32.9% |
| 2015 | 0.65x | NT$498.81 Million | NT$472.15 Million | NT$764.69 Million | ▲ +52.5% |
| 2014 | 0.43x | NT$333.02 Million | NT$267.60 Million | NT$778.52 Million | ▼ -53.1% |
| 2013 | 0.91x | NT$732.45 Million | NT$484.77 Million | NT$803.47 Million | ▼ -27.5% |
| 2012 | 1.26x | NT$924.37 Million | NT$509.67 Million | NT$735.18 Million | ▲ +40.4% |
| 2011 | 0.90x | NT$348.08 Million | NT$273.45 Million | NT$388.76 Million | ▼ -54.2% |
| 2010 | 1.95x | NT$626.64 Million | NT$465.59 Million | NT$320.60 Million | ▲ +27.6% |
| 2009 | 1.53x | NT$464.62 Million | NT$391.29 Million | NT$303.31 Million | ▼ -21.1% |
| 2008 | 1.94x | NT$429.70 Million | NT$299.96 Million | NT$221.21 Million | ▼ -5.1% |
| 2007 | 2.05x | NT$419.34 Million | NT$364.62 Million | NT$204.80 Million | ▼ -1.2% |
| 2006 | 2.07x | NT$405.70 Million | NT$363.71 Million | NT$195.73 Million | ▲ +57.8% |
| 2005 | 1.31x | NT$293.44 Million | NT$212.14 Million | NT$223.36 Million | ▼ -64.0% |
| 2004 | 3.65x | NT$469.70 Million | NT$218.54 Million | NT$128.64 Million | ▲ +24.3% |
| 2003 | 2.94x | NT$358.46 Million | NT$302.25 Million | NT$122.00 Million | ▲ +86.4% |
| 2002 | 1.58x | NT$140.62 Million | NT$79.49 Million | NT$89.21 Million | — |